Story perspectives
FDA's Prasad Questions Vaccine Safety Amid Controversy
12/20/2025
1 of 2
Prasad Proposes Vaccine Changes
- Dr. Vinay Prasad, head of the FDA's Center for Biologics Evaluation and Research, proposed changes to vaccine approval processes, arguing current methods downplay COVID-19 vaccine risks.
- He claimed at least 10 child deaths were linked to these vaccines.
- Former FDA commissioners criticized the claim as lacking evidence and potentially undermining public trust.
- The FDA is investigating these claims and considering ethical concerns of proposed studies in Guinea-Bissau.
1 / 2
